| Favipiravir (T-705), a novel viral RNA polymerase inhibitor Y Furuta, BB Gowen, K Takahashi, K Shiraki, DF Smee, DL Barnard Antiviral research 100 (2), 446-454, 2013 | 1225 | 2013 |
| T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections Y Furuta, K Takahashi, K Shiraki, K Sakamoto, DF Smee, DL Barnard, ... Antiviral research 82 (3), 95-102, 2009 | 548 | 2009 |
| Variation in lipid A structure in the pathogenic yersiniae R Rebeil, RK Ernst, BB Gowen, SI Miller, BJ Hinnebusch Molecular microbiology 52 (5), 1363-1373, 2004 | 331 | 2004 |
| In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections BB Gowen, MH Wong, KH Jung, AB Sanders, M Mendenhall, KW Bailey, ... Antimicrobial agents and chemotherapy 51 (9), 3168-3176, 2007 | 301 | 2007 |
| Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease X Ma, Y Liu, BB Gowen, EA Graviss, AG Clark, JM Musser PloS one 2 (12), e1318, 2007 | 248 | 2007 |
| Kinetics of disease progression and host response in a rat model of bubonic plague F Sebbane, D Gardner, D Long, BB Gowen, BJ Hinnebusch The American journal of pathology 166 (5), 1427-1439, 2005 | 219 | 2005 |
| Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies MR Graham, K Virtaneva, SF Porcella, WT Barry, BB Gowen, CR Johnson, ... The American journal of pathology 166 (2), 455-465, 2005 | 168 | 2005 |
| TLR3 deletion limits mortality and disease severity due to Phlebovirus infection BB Gowen, JD Hoopes, MH Wong, KH Jung, KC Isakson, L Alexopoulou, ... The Journal of Immunology 177 (9), 6301-6307, 2006 | 158 | 2006 |
| TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly (I: C12U), but not Poly (I: C … BB Gowen, MH Wong, KH Jung, AB Sanders, WM Mitchell, L Alexopoulou, ... The Journal of Immunology 178 (8), 5200-5208, 2007 | 154 | 2007 |
| T-705 (favipiravir) inhibition of arenavirus replication in cell culture M Mendenhall, A Russell, T Juelich, EL Messina, DF Smee, AN Freiberg, ... Antimicrobial agents and chemotherapy 55 (2), 782-787, 2011 | 128 | 2011 |
| The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset D Safronetz, K Rosenke, JB Westover, C Martellaro, A Okumura, Y Furuta, ... Scientific reports 5 (1), 14775, 2015 | 123 | 2015 |
| Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever M Mendenhall, A Russell, DF Smee, JO Hall, R Skirpstunas, Y Furuta, ... PLoS neglected tropical diseases 5 (10), e1342, 2011 | 121 | 2011 |
| Insight into the molecular basis of pathogen abundance: Group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human … NP Hoe, RM Ireland, FR DeLeo, BB Gowen, DW Dorward, JM Voyich, ... Proceedings of the National Academy of Sciences 99 (11), 7646-7651, 2002 | 120 | 2002 |
| Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment D Scharton, KW Bailey, Z Vest, JB Westover, Y Kumaki, A Van Wettere, ... Antiviral research 104, 84-92, 2014 | 109 | 2014 |
| Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin BB Gowen, DF Smee, MH Wong, JO Hall, KH Jung, KW Bailey, ... PloS one 3 (11), e3725, 2008 | 105 | 2008 |
| Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome D Safronetz, D Falzarano, DP Scott, Y Furuta, H Feldmann, BB Gowen Antimicrobial agents and chemotherapy 57 (10), 4673-4680, 2013 | 102 | 2013 |
| Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses BB Gowen, MR Holbrook Antiviral research 78 (1), 79-90, 2008 | 100 | 2008 |
| Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors BB Gowen, TK Borg, A Ghaffar, EP Mayer Matrix Biology 19 (1), 61-71, 2000 | 94 | 2000 |
| Use of favipiravir to treat Lassa virus infection in macaques K Rosenke, H Feldmann, JB Westover, PW Hanley, C Martellaro, ... Emerging infectious diseases 24 (9), 1696, 2018 | 90 | 2018 |
| Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever BB Gowen, TL Juelich, EJ Sefing, T Brasel, JK Smith, L Zhang, B Tigabu, ... PLoS neglected tropical diseases 7 (12), e2614, 2013 | 86 | 2013 |
